ألفا D3 ٠.٢٥ مكغ كبسولات إسرائيل - العربية - Ministry of Health

ألفا d3 ٠.٢٥ مكغ كبسولات

teva pharmaceutical indust.ltd - alfacalcidol 0.25 mcg - capsules soft gelatin - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

ألفا D3 ١.٠ مكغ كبسولات إسرائيل - العربية - Ministry of Health

ألفا d3 ١.٠ مكغ كبسولات

teva pharmaceutical indust.ltd - alfacalcidol 1 mcg - capsules soft gelatin - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

ﺳپيرونولاكتون تيڤع ١٠٠ ملغ إسرائيل - العربية - Ministry of Health

ﺳپيرونولاكتون تيڤع ١٠٠ ملغ

teva pharmaceutical indust.ltd - spironolactone 100 mg - tablets - spironolactone - edematous conditions: congestive heart failure; cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. essential hypertention. primary hyperaldostronism. hypokalemia.

پنيﺪيل ١٠ ملغ أقراص ذات مفعول ممتد إسرائيل - العربية - Ministry of Health

پنيﺪيل ١٠ ملغ أقراص ذات مفعول ممتد

teva pharmaceutical indust.ltd - felodipine 10 mg - tablets extended release - felodipine - moderate to severe hypertension. angina pectoris.

پنيﺪيل ٢.٥ ملغ أقراص ذات مفعول ممتد إسرائيل - العربية - Ministry of Health

پنيﺪيل ٢.٥ ملغ أقراص ذات مفعول ممتد

teva pharmaceutical indust.ltd - felodipine 2.5 mg - tablets extended release - felodipine - hypertension. angina pectoris.

روزوڤاساتين تيڤع ١٠ ملغ إسرائيل - العربية - Ministry of Health

روزوڤاساتين تيڤع ١٠ ملغ

teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.